ACLY: A biomarker of recurrence in breast cancer.

•ACLY is significantly upregulated in breast cancer tissue.•ACLY expression is associated with poor prognosis-associated clinical variables.•Upregulated ACLY predicts worse relapse-free survival of breast cancer patients.•ACLY over-expression induces the resistance of breast cancer cells to docetaxel.